HBCM
UTHR icon

Heron Bay Capital Management’s United Therapeutics UTHR Stock Holding History

Heron Bay Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4,345
Closed -$2.58M – 108
2026
Q1 		$2.58M Buy
4,345
+545
+14% +$271K 0.24% 45
2025
Q4 		$1.85M Sell
3,800
-19
-0.5% -$8.85K 0.35% 45
2025
Q3 		$1.6M Sell
3,819
-39
-1% -$13.1K 0.3% 47
2025
Q2 		$1.11M Buy
+3,858
New +$1.15M 0.22% 49

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Heron Bay Capital Management's UTHR Position: Q2 2026 in Review

Heron Bay Capital Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 4,345 shares — an estimated $2.58M sold.

Heron Bay Capital Management first reported a position in UTHR in Q2 2025 and held it in 4 quarters. The position peaked at $2.58M in Q1 2026. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Heron Bay Capital Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Heron Bay Capital Management sold 4,345 United Therapeutics shares in Q2 2026, an estimated $2.58M.
  • Heron Bay Capital Management first reported a position in United Therapeutics in Q2 2025 and held it in 4 quarters.
  • Heron Bay Capital Management's United Therapeutics position peaked at $2.58M in Q1 2026.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Heron Bay Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.